Insmed | Lucro Por Ação



Fiscal Calendário Atual Consenso Anterior Data
FY2025Q1 Mar/2025 -1.2 -1.06 May/01 2025
FY2024Q4 Dec/2024 -1.32 -1.18 -1.28 Feb/20 2025
FY2024Q3 Sep/2024 -1.27 -1.20 -1.11 Oct/31 2024
FY2024Q2 Jun/2024 -1.94 -1.24 -1.78 Aug/08 2024
FY2024Q1 Mar/2024 -1.06 -1.23 -1.17 May/09 2024
FY2023Q4 Dec/2023 -1.28 -1.16 -1.21 Feb/22 2024
FY2023Q3 Sep/2023 -1.11 -1.13 -1.09 Oct/26 2023
FY2023Q2 Jun/2023 -1.78 -1.16 -0.8 Aug/03 2023
FY2023Q1 Mar/2023 -1.17 -1.13 -0.8 May/04 2023
FY2022Q4 Dec/2022 -1.21 -1.05 -0.95 Feb/23 2023
FY2022Q3 Sep/2022 -1.09 -0.88 -0.89 Oct/27 2022
FY2022Q2 Jun/2022 -0.8 -0.89 -0.91 Aug/04 2022

Eps Alterar Data
BioMarin Pharmaceutical USD 0.64 0.09 2024-12
Cytokinetics USD -1.26 0.1 2024-12
DBV Technologies EUR -1.6 0.1 2024-09
Dynavax Technologies USD 0.05 0.07 2024-12
Gilead Sciences USD 1.9 0.12 2024-12
Insmed USD -1.32 0.04 2024-12
Novartis USD 1.98 0.08 2024-12
Regeneron Pharmaceuticals USD 12.07 0.39 2024-12
Sarepta Therapeutics USD 1.5 1.16 2024-12
Ultragenyx Pharmaceutical USD -1.39 0.01 2024-12
Vertex Pharmaceuticals USD 3.98 0.4 2024-12



Insmed Lucro Por Ação - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2025.